Longitudinal multimodal assessment of peripheral nerve involvement in wild-type transthyretin amyloidosis

INTRODUCTION: Wild-type transthyretin amyloidosis (ATTRwt) is a progressive disease marked by extracellular transthyretin amyloid deposition, predominantly causing cardiomyopathy. Neurological manifestations are known in hereditary ATTR but remain comparatively understudied in ATTRwt. METHODS: Patients with ATTRwt cardiomyopathy were prospectively evaluated at baseline and after 1 year, alongside healthy controls. Neurological assessment included Neuropathy Impairment Score Lower Limb (NIS-LL), nerve conduction studies, quantitative sensory testing (QST), serum neurofilament light chain (sNfL), and intra-epidermal nerve fiber density (IENFD) from skin biopsies. Symptoms and fatigue were assessed using Norfolk-QoL-DN and Chalder Fatigue scale. RESULTS: Twenty-three patients were included and compared to controls. Pathological IENFD occurred in 47.8% of patients vs. 4.3% of controls (p=0.002). In ATTRwt, except cold detection, all QST parameters were abnormal. Sensory-predominant axonal polyneuropathy was present in 82.6%, with higher NIS-LL and symptom burden (p<0.001). sNfL levels were similar between groups. Carpal tunnel syndrome was frequent (82.7%). Polyneuropathy with CTS was more common in ATTRwt (p=0.025). At follow-up, we observed no clinical or electrophysiological progression, and no newly diagnosed cases of polyneuropathy. CONCLUSIONS: ATTRwt is associated with mixed fiber neuropathy and frequent entrapment neuropathies which should raise suspicion for ATTRwt. We found subtle clinical progression over 13 months.

Authors

Institutions

Publication Details

Journal
Journal of Neurology
Published
2026-08-25
DOI
https://doi.org/10.1007/s00415-026-14066-8
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Longitudinal multimodal assessment of peripheral nerve involvement in wild-type transthyretin amyloidosis

Anna Hotter, Maria Ungericht, Gerhard Pölzl, Corinne G.C. Horlings et al.
Journal of Neurology
Amyloidosis: Diagnosis, Treatment, Outcomes
article

Longitudinal multimodal assessment of peripheral nerve involvement in wild-type transthyretin amyloidosis

Anna Hotter, Maria Ungericht, Gerhard Pölzl, Corinne G.C. Horlings, Vera E. A. Kleinveld, Julia Wanschitz, Petra Sanders, Wolfgang N. Löscher, Alessandra Fanciulli
article en

Abstract

INTRODUCTION: Wild-type transthyretin amyloidosis (ATTRwt) is a progressive disease marked by extracellular transthyretin amyloid deposition, predominantly causing cardiomyopathy. Neurological manifestations are known in hereditary ATTR but remain comparatively understudied in ATTRwt. METHODS: Patients with ATTRwt cardiomyopathy were prospectively evaluated at baseline and after 1 year, alongside healthy controls. Neurological assessment included Neuropathy Impairment Score Lower Limb (NIS-LL), nerve conduction studies, quantitative sensory testing (QST), serum neurofilament light chain (sNfL), and intra-epidermal nerve fiber density (IENFD) from skin biopsies. Symptoms and fatigue were assessed using Norfolk-QoL-DN and Chalder Fatigue scale. RESULTS: Twenty-three patients were included and compared to controls. Pathological IENFD occurred in 47.8% of patients vs. 4.3% of controls (p=0.002). In ATTRwt, except cold detection, all QST parameters were abnormal. Sensory-predominant axonal polyneuropathy was present in 82.6%, with higher NIS-LL and symptom burden (p<0.001). sNfL levels were similar between groups. Carpal tunnel syndrome was frequent (82.7%). Polyneuropathy with CTS was more common in ATTRwt (p=0.025). At follow-up, we observed no clinical or electrophysiological progression, and no newly diagnosed cases of polyneuropathy. CONCLUSIONS: ATTRwt is associated with mixed fiber neuropathy and frequent entrapment neuropathies which should raise suspicion for ATTRwt. We found subtle clinical progression over 13 months.

Journal of NeurologyVol. 273(9)
Innsbruck Medical University (AT), Universität Innsbruck (AT), Tirol Kliniken (AT)
Pfizer, Medizinische Universität Innsbruck, Universität Innsbruck
Good health and well-being
Openalex Percentile: Top 17%
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.